Life Sciences
Life Sciences 25
Biogen Idec's partner on the blockbuster drug Rituxan, Genentech, reported a sales surge; Alnylam Pharmaceuticals and Novartis decided to extend an RNAi therapeutics collaboration for another year.
| LAST | MRKT. CAP | LAST | PCT. | |||
| NO. | WK. | COMPANY | TICKER | (millions) | PRICE | CHANGE |
| 1 | 1 | Covidien Ltd. | COV | $24,494 | $49.03 | 0.3% |
| 2 | 2 | Thermo Fisher Scientific | TMO | $23,395 | $55.94 | -2.1% |
| 3 | 3 | Genzyme Corp. | GENZ | $20,912 | $78.23 | 3.4% |
| 4 | 5 | Boston Scientific Corp. | BSX | $20,783 | $13.89 | 14.9% |
| 5 | 4 | Biogen Idec | BIIB | $18,944 | $64.65 | 3.9% |
| 6 | 6 | Waters Corp. | WAT | $6,276 | $62.70 | -3.8% |
| 7 | 7 | Hologic | HOLX | $6,133 | $23.97 | 6.2% |
| 8 | 8 | Vertex Pharmaceuticals | VRTX | $4,487 | $31.92 | -3.8% |
| 9 | 9 | Charles River Laboratories | CRL | $4,317 | $63.36 | -0.5% |
| 10 | 10 | Millipore Corp. | MIL | $3,930 | $71.34 | 7.4% |
| 11 | 11 | PerkinElmer | PKI | $3,262 | $27.55 | -2.5% |
| 12 | 12 | Inverness Medical Innov. | IMA | $2,434 | $31.37 | 2.0% |
| 13 | 13 | Sepracor | SEPR | $2,240 | $20.78 | 3.2% |
| 14 | 14 | Bruker Corp. | BRKR | $1,934 | $11.84 | -6.0% |
| 15 | 15 | Parexel International Corp. | PRXL | $1,527 | $26.98 | 4.3% |
| 16 | 17 | Alkermes | ALKS | $1,380 | $14.44 | 5.2% |
| 17 | 16 | Haemonetics Corp. | HAE | $1,370 | $53.66 | 0.1% |
| 18 | 18 | Alnylam Pharmaceuticals | ALNY | $1,280 | $31.35 | 8.3% |
| 19 | 19 | Cubist Pharmaceuticals | CBST | $1,124 | $19.94 | 2.8% |
| 20 | 20 | Phase Forward | PFWD | $841 | $19.65 | 7.0% |
| 21 | 21 | Zoll Medical Corp. | ZOLL | $683 | $32.70 | -9.4% |
| 22 | 22 | Abiomed | ABMD | $614 | $18.43 | 1.3% |
| 23 | 23 | AMAG Pharmaceuticals | AMAG | $586 | $34.47 | -1.4% |
| 24 | 24 | Momenta Pharmaceuticals | MNTA | $557 | $15.14 | 9.0% |
| 25 | 25 | Insulet Corp. | PODD | $434 | $15.77 | -3.4% |
The Boston Globe/Bloomberg Massachusetts Technology and Life Sciences indexes are price-weighted indexes of all technology and life sciences stocks in the state. Listed above are the top companies, ranked by market value, in each sector. Asterisks indicate a stock that has moved five places or more in the last week. For up-to-the-minute rankings and stock prices, visit boston.com/business.
© Copyright 2008 Globe Newspaper Company.
